Literature DB >> 26506055

What to expect from molecular tools for non-documented pediatric infectious diseases.

Anne Filleron1,2, Anne-Laure Michon3,4, Estelle Jumas-Bilak3,5, Eric Jeziorski6, Isabelle Zorgniotti3, Tu Anh Tran1,2, Thomas Filleron7, Michel Rodière6, Hélène Marchandin3,4.   

Abstract

OBJECTIVE: Evaluation of the contribution of molecular tools to the overall diagnosis of infectious diseases in children.
METHODS: Results of 16S rDNA analysis (179 children; 228 specimens), combined to specific amplification of Kingella kingae (126 children; 166 osteoarticular specimens), were retrospectively analyzed for samples with inconclusive cultures. RESULT: The overall positive yield in diagnosis was 12.8% of the patients for 16S rDNA PCR, 40.5% for K. kingae PCR and 45.2% for combined use of both methods. Results were related to clinical and biological data (direct examination, certainty/uncertainty of clinical diagnosis, fever, biological markers, previous antibiotics), and to the number of samples analyzed per patient, allowing the identification of specific situations with significant contribution of PCR methods.
CONCLUSION: Molecular techniques constitute valuable tools to improve the bacterial infection diagnosis in children; however, specific indications, dedicated samples, and number of analyzed samples per patient are key points to optimize their contribution.

Entities:  

Keywords:  16S rRNA gene; DNA sequencing; Kingella kingae; PCR; children; infectious diseases

Mesh:

Substances:

Year:  2015        PMID: 26506055     DOI: 10.1586/14737159.2015.1105132

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  1 in total

1.  Molecular Tests That Target the RTX Locus Do Not Distinguish between Kingella kingae and the Recently Described Kingella negevensis Species.

Authors:  Nawal El Houmami; Janek Bzdrenga; Guillaume André Durand; Philippe Minodier; Hervé Seligmann; Elsa Prudent; Sofiane Bakour; Stéphane Bonacorsi; Didier Raoult; Pablo Yagupsky; Pierre-Edouard Fournier
Journal:  J Clin Microbiol       Date:  2017-08-09       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.